Skip to Main Content

Paper Details

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
Cancer Cell
356
2017
Aurora Kinase, Aurora kinase, MYC, Myc, NEUROD1, Neuroendocrine Subtype, RB1, Rb1, SCLC, Small Cell Lung Cancer, TP53, Trp53, human, human SCLC, metastatic, mouse, neuroendocrine-low "variant" subset, patient, small cell lung cancer, tumor, tumors
Author NameAffiliation
Ismail CanUniversity of Utah, Huntsman Cancer Institute
Haixia ChengUniversity of Utah, Huntsman Cancer Institute
Anandaroop MukhopadhyayUniversity of Utah, Huntsman Cancer Institute
Jeffery M VahrenkampUniversity of Utah, Huntsman Cancer Institute
Kristofer C BerrettUniversity of Utah, Huntsman Cancer Institute
Jason GertzUniversity of Utah, Huntsman Cancer Institute
Robert J Wechsler-ReyaSanford Burnham Prebys Medical Discovery Institute
Robert J Wechsler-ReyaSanford Burnham Prebys Medical Discovery Institute
Martin L SosInstitute for Pathology, University of Cologne
Trudy G OliverUniversity of Utah, Huntsman Cancer Institute
  • 1 - 10

Datasets

Release 1.2